肠道菌群抗病毒机制研究进展

doi:10.11843/j.issn.0366-6964.2023.12.003

摘要/Abstract

摘要： 近年来,由于对肠道中菌群的研究不断深化,同时对肠道菌群和机体健康的关系也有了更加清晰的认识,发现肠道菌群对病毒的感染有着双重调节的作用。肠道菌群可以通过保护肠黏膜屏障以及直接与病毒结合进而中和病毒或者阻止病毒对细胞黏附的直接作用抑制病毒感染,或通过对机体免疫系统建立和发育产生影响的间接方式来抑制病毒的入侵以及分泌具有抗病毒作用的代谢产物来发挥抗病毒作用;此外,益生菌在疾病治疗中的作用也越来越突出,有望从益生菌入手解决当前治疗病毒性疾病的弊端。本文着重对近年来肠道菌群抵抗病毒感染的相关机制研究进展进行综述,并对此方向相关问题及进一步的相关研究进行展望。

关键词: 肠道菌群, 抗病毒机制, 黏膜屏障, 免疫调节, 菌群代谢物

Abstract: In recent years, with the deepening research on the intestinal microbiota and a clearer understanding of its relationship with organismal health, it has been found that the intestinal microbiota plays a dual role in regulating viral infections. The intestinal microbiota can inhibit viral infection by protecting the intestinal mucosal barrier, directly neutralizing viruses or preventing their effects on cell adhesion, indirectly influencing the establishment and development of the body's immune system, and secreting antiviral metabolites to play an antiviral role. Moreover, probiotics have played an increasingly prominent role in disease treatment, and it is expected that probiotics can overcome the disadvantages of current viral disease treatments. This paper reviews the research progress on the mechanisms of the intestinal microbiota's resistance to viral infection in recent years and discusses related issues and future directions for research.

Key words: intestinal microflora, antivirus mechanism, mucosal barrier, immunomodulation, microbial metabolites

中图分类号:

S852.4

宫浩阳, 吴佳鑫, 杨晓钰, 解伟纯, 王雪莹, 李佳璇, 姜艳平, 崔文, 李一经, 唐丽杰. 肠道菌群抗病毒机制研究进展[J]. 畜牧兽医学报, 2023, 54(12): 4910-4919.

GONG Haoyang, WU Jiaxin, YANG Xiaoyu, XIE Weichun, WANG Xueying, LI Jiaxuan, JIANG Yanping, CUI Wen, LI Yijing, TANG Lijie. Research Progress in Antiviral Mechanism of Intestinal Microflora[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(12): 4910-4919.

参考文献

[1] NORMAN J M, HANDLEY S A, VIRGIN H W. Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities[J]. Gastroenterology, 2014, 146(6):1459-1469.
[2] LI Y X, XIA S T, JIANG X H, et al. Gut microbiota and diarrhea: An updated review[J]. Front Cell Infect Microbiol, 2021, 11:625210.
[3] DOMÍNGUEZ-DÍAZ C, GARCÍA-OROZCO A, RIERA-LEAL A, et al. Microbiota and its role on viral evasion:Is it with us or against us?[J]. Front Cell Infect Microbiol, 2019, 9:450548.
[4] 杨靖源, 蒙俊, 杨堃. 肠紧密连接蛋白与肠道屏障功能[J]. 医学综述, 2022, 28(2):235-239.YANG J Y, MENG J, YANG K. Intestinal tight junction protein and intestinal barrier function[J]. Medical Recapitulate, 2022, 28(2):235-239. (in Chinese)
[5] FARQUHAR M G, PALADE G E. Junctional complexes in various epithelia[J]. J Cell Biol, 1963, 17(2):375-412.
[6] ULLUWISHEWA D, ANDERSON R C, MCNABB W C, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components[J]. J Nutr, 2011, 141(5):769-776.
[7] KARCZEWSKI J, TROOST F J, KONINGS I, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(6):G851-G859.
[8] KANMANI P, KIM H. Immunobiotic strains modulate toll-like receptor 3 agonist induced innate antiviral immune response in human intestinal epithelial cells by modulating IFN regulatory factor 3 and NF-κB signaling[J]. Front Immunol, 2019, 10:1536.
[9] MAO X B, GU C S, HU H Y, et al. Dietary Lactobacillus rhamnosus GG supplementation improves the mucosal barrier function in the intestine of weaned piglets challenged by porcine rotavirus[J]. PLoS One, 2016, 11(1):e0146312.
[10] YAN F, POLK D B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells[J]. J Biol Chem, 2002, 277(52):50959-50965.
[11] ZHAO X H, ZHOU J, LIANG W H, et al. Probiotics mixture reinforces barrier function to ameliorate necrotizing enterocolitis by regulating PXR-JNK pathway[J]. Cell Biosci, 2021, 11(1):20.
[12] UKENA S N, SINGH A, DRINGENBERG U, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity[J]. PLoS One, 2007, 2(12):e1308.
[13] MADSEN K, CORNISH A, SOPER P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function[J]. Gastroenterology, 2001, 121(3):580-591.
[14] THOREUX K, BALAS D, BOULEY C, et al. Diet supplemented with yoghurt or milk fermented by Lactobacillus casei DN-114001 stimulates growth and brush-border enzyme activities in mouse small intestine[J]. Digestion, 1998, 59(4):349-359.
[15] FREITAS M, TAVAN E, CAYUELA C, et al. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game[J]. Biol Cell, 2003, 95(8):503-506.
[16] KEBOUCHI M, HAFEEZ Z, LE ROUX Y, et al. Importance of digestive mucus and mucins for designing new functional food ingredients[J]. Food Res Int, 2020, 131:108906.
[17] ENGEVIK M A, VISUTHRANUKUL C, LUCK B, et al. Bifidobacterium dentium upregulates intestinal SERT via the JNK pathway and stimulates serotonin release[J]. Gastroenterology, 2017, 152(5):S103-S104.
[18] ROKANA N, MALLAPPA R H, BATISH V K, et al. Interaction between putative probiotic Lactobacillus strains of Indian gut origin and Salmonella:Impact on intestinal barrier function[J]. LWT, 2017, 84:851-860.
[19] WANG Z Y, CHAI W D, BURWINKEL M, et al. Inhibitory influence of Enterococcus faecium on the propagation of swine influenza A virus in vitro[J]. PLoS One, 2013, 8(1):e53043.
[20] WANG X, HU W, ZHU L, et al. Bacillus subtilis and surfactin inhibit the transmissible gastroenteritis virus from entering the intestinal epithelial cells[J]. Biosci Rep, 2017, 37(2):BSR20170082. doi: 10.1042/BSR20170082.
[21] AL KASSAA I, HOBER D, HAMZE M, et al. Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2[J]. Arch Microbiol, 2015, 197(5):657-664.
[22] VARYUKHINA S, FREITAS M, BARDIN S, et al. Glycan-modifying bacteria-derived soluble factors from Bacteroides thetaiotaomicron and Lactobacillus casei inhibit rotavirus infection in human intestinal cells[J]. Microbes Infect, 2012, 14(3):273-278.
[23] GUANDALINI S, PENSABENE L, ZIKRI M A, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea:a multicenter European trial[J]. J Pediatr Gastroenterol Nutr, 2000, 30(1):54-60.
[24] JONES M K, WATANABE M, ZHU S, et al. Enteric bacteria promote human and mouse norovirus infection of B cells[J]. Science, 2014, 346(6210):755-759.
[25] RUBIO-DEL-CAMPO A, COLL-MARQUÉS J M, YEBRA M J, et al. Noroviral P-particles as an in vitro model to assess the interactions of noroviruses with probiotics[J]. PLoS One, 2014, 9(2):e89586.
[26] KANDASAMY S, VLASOVA A N, FISCHER D, et al. Differential effects of Escherichia coli Nissle and Lactobacillus rhamnosus strain GG on human rotavirus binding, infection, and B cell immunity[J]. J Immunol, 2016, 196(4):1780-1789.
[27] LEI S H, RAMESH A, TWITCHELL E, et al. High protective efficacy of probiotics and rice bran against human norovirus infection and diarrhea in gnotobiotic pigs[J]. Front Microbiol, 2016, 7:1699.
[28] VAN DEN ELSEN L W J, POYNTZ H C, WEYRICH L S, et al. Embracing the gut microbiota:the new frontier for inflammatory and infectious diseases[J]. Clin Trans Immunol, 2017, 6(1):e125.
[29] PELASEYED T, BERGSTRÖM J H, GUSTAFSSON J K, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system[J]. Immunol Rev, 2014, 260(1):8-20.
[30] MATSUSAKI T, TAKEDA S, TAKESHITA M, et al. Augmentation of T helper type 1 immune response through intestinal immunity in murine cutaneous herpes simplex virus type 1 infection by probiotic Lactobacillus plantarum strain 06CC2[J]. Int Immunopharmacol, 2016, 39:320-327.
[31] AOKI-YOSHIDA A, SAITO S, FUKIYA S, et al. Lactobacillus rhamnosus GG increases Toll-like receptor 3 gene expression in murine small intestine ex vivo and in vivo[J]. Benef Microbes, 2016, 7(3):421-429.
[32] INDO Y, KITAHARA S, TOMOKIYO M, et al. Ligilactobacillus salivarius strains isolated from the porcine gut modulate innate immune responses in epithelial cells and improve protection against intestinal viral-bacterial superinfection[J]. Front Immunol, 2021, 12:652923.
[33] WEISS G, RASMUSSEN S, ZEUTHEN L H, et al. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism[J]. Immunology, 2010, 131(2):268-281.
[34] RICE T A, BRENNER T A, PERCOPO C N, et al. Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection[J]. Antiviral Res, 2016, 132:131-140.
[35] MACPHERSON C, AUDY J, MATHIEU O, et al. Multistrain probiotic modulation of intestinal epithelial cells' immune response to a double-stranded RNA ligand, poly(I·C)[J]. Appl Environm Microbiol, 2014, 80(5):1692-1700.
[36] 王剑, 陈雪苹, 李继昌. 唾液乳杆菌对鸡毒支原体感染肉鸡生长性能及肺损伤的影响[J]. 畜牧兽医学报, 2022, 53(9): 3172-3179.WANG J, CHEN X P, LI J C. Effects of Lactobacillus salivary on growth performance and lung injury of broilers challenged with Mycoplasma gallisepticum[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(9): 3172-3179. (in Chinese)
[37] STEFAN K L, KIM M V, IWASAKI A, et al. Commensal microbiota modulation of natural resistance to virus infection[J]. Cell, 2020, 183(5):1312-1324. e10.
[38] STEED A L, CHRISTOPHI G P, KAIKO G E, et al. The microbial metabolite desaminotyrosine protects from influenza through type I interferon[J]. Science, 2017, 357(6350):498-502.
[39] SCHAUPP L, MUTH S, ROGELL L, et al. Microbiota-induced type I interferons instruct a poised basal state of dendritic cells[J]. Cell, 2020, 181(5):1080-1096. e19.
[40] WANG K, RAN L, YAN T, et al. Anti-TGEV miller strain infection effect of Lactobacillus plantarum supernatant based on the JAK-STAT1 signaling pathway[J]. Front Microbiol, 2019, 10:2540.
[41] KARAFFOVÁ V, CSANK T, MUDROŇOVÁ D, et al. Influence of Lactobacillus reuteri L26 Biocenol^TM on immune response against porcine circovirus type 2 infection in germ-free mice[J]. Benef Microbes, 2017, 8(3):367-378.
[42] JUNG Y J, LEE Y T, NGO V L, et al. Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection[J]. Sci Rep, 2017, 7(1):17360.
[43] XIA Z B, HAN Y J, WANG K, et al. Oral administration of propionic acid during lactation enhances the colonic barrier function[J]. Lipids Health Dis, 2017, 16(1):62.
[44] FENG W Q, WU Y C, CHEN G X, et al. Sodium butyrate attenuates diarrhea in weaned piglets and promotes tight junction protein expression in colon in a GPR109A-dependent manner[J]. Cell Physiol Biochem, 2018, 47(4):1617-1629.
[45] KAYAMA H, OKUMURA R, TAKEDA K. Interaction between the microbiota, epithelia, and immune cells in the intestine[J]. Annu Rev Immunol, 2020, 38:23-48.
[46] YANG W J, YU T M, HUANG X S, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity[J]. Nat Commun, 2020, 11(1):4457.
[47] MORITA N, UMEMOTO E, FUJITA S, et al. GPR31-dependent dendrite protrusion of intestinal CX3CR1⁺ cells by bacterial metabolites[J]. Nature, 2019, 566(7742):110-114.
[48] FENG Y H, WANG Y, WANG P, et al. Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy[J]. Cell Physiol Biochem, 2018, 49(1):190-205.
[49] 杨晓炼. 布劳特球菌通过乙酸介导宿主Ⅰ型干扰素抗肠道病毒天然免疫的分子机制研究[D]. 杭州:浙江大学, 2021.YANG X L. Research on molecular mechanism of Blautia coccoides priming host innate immunity against enteric virus mediated by type I interferon through acetic acid[D]. Hangzhou: Zhejiang University, 2021. (in Chinese)
[50] DONG F C, HAO F H, MURRAY I A, et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity[J]. Gut Microbes, 2020, 12(1):1788899.
[51] CERVANTES-BARRAGAN L, CHAI J N, TIANERO M D, et al. Lactobacillus reuteri induces gut intraepithelial CD4⁺ CD8αα⁺ T cells[J]. Science, 2017, 357(6353):806-810.
[52] WILLIAMS B B, VAN BENSCHOTEN A H, CIMERMANCIC P, et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine[J]. Cell Host Microbe, 2014, 16(4):495-503.
[53] JING W H, DONG S J, LUO X L, et al. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites[J]. Pharmacol Res, 2021, 164:105358.
[54] ZHANG J, ZHU S W, MA N, et al. Metabolites of microbiota response to tryptophan and intestinal mucosal immunity:A therapeutic target to control intestinal inflammation[J]. Med Res Rev, 2021, 41(2):1061-1088.
[55] VAN TILBURG BERNARDES E, PETTERSEN V K, GUTIERREZ M W, et al. Intestinal fungi are causally implicated in microbiome assembly and immune development in mice[J]. Nat Commun, 2020, 11(1):2577.
[56] DORON I, LEONARDI I, LI X V, et al. Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies[J]. Cell, 2021, 184(4):1017-1031. e14.
[57] NGUI I Q H, PERERA A P, ERI R. Does NLRP3 inflammasome and Aryl hydrocarbon receptor play an interlinked role in bowel inflammation and colitis-associated colorectal cancer?[J]. Molecules, 2020, 25(10):2427.
[58] KOTHARI D, PATEL S, KIM S K. Probiotic supplements might not be universally-effective and safe:A review[J]. Biomed Pharmacother, 2019, 111:537-547.
[59] DENG L, XU H C, LIU P, et al. Prolonged exposure to high humidity and high temperature environment can aggravate influenza virus infection through intestinal flora and Nod/RIP2/NF-κB signaling pathway[J]. Vet Microbiol, 2020, 251:108896.
[60] BOSCH T C G, ZASLOFF M. Antimicrobial peptides-or how our ancestors learned to control the microbiome[J]. mBio, 2021, 12(5):e0184721.
[61] ERMOLENKO E I, DESHEVA Y A, KOLOBOV A A, et al. Anti-influenza activity of Enterocin B in vitro and protective effect of bacteriocinogenic enterococcal probiotic strain on influenza infection in mouse model[J]. Probiotics Antimicrob Proteins, 2019, 11(2):705-712.
[62] WACHSMAN M B, CASTILLA V, DE RUIZ HOLGADO A P, et al. Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro[J]. Antiviral Res, 2003, 58(1):17-24.
[63] SERKEDJIEVA J, DANOVA S, IVANOVA I. Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii[J]. Appl Biochem Biotechnol, 2000, 88(1-3):285-298.
[64] ANWAR F, ALTAYB H N, AL-ABBASI F A, et al. Antiviral effects of probiotic metabolites on COVID-19[J]. J Biomol Struct Dyn, 2021, 39(11):4175-4184.
[65] ZHAI S S, RUAN D, ZHU Y W, et al. Protective effect of curcumin on ochratoxin A-induced liver oxidative injury in duck is mediated by modulating lipid metabolism and the intestinal microbiota[J]. Poult Sci, 2020, 99(2):1124-1134.
[66] SAADAT Y R, KHOSROUSHAHI A Y, GARGARI B P. A comprehensive review of anticancer, immunomodulatory and health beneficial effects of the lactic acid bacteria exopolysaccharides[J]. Carbohydr Polym, 2019, 217:79-89.
[67] YILDIZ B M, YUZBASIOGLU D, YUKSEKDAG Z, et al. In vitro genotoxic and antigenotoxic effects of an exopolysaccharide isolated from Lactobacillus salivarius KC27L[J]. Toxicol In Vitro, 2023, 86:105507.
[67] SHARMA V, GHOSH M. Characterization of immunomodulatory, anticancer and antioxidant properties of an extracellular polymer produced by Enterococcus sp. in vegetable waste medium[J]. Environ Sustain, 2021, 4(2):419-428.
[68] ABED S M, ESSA R H, ALARAJI K H Y. Evaluation of the antibacterial activity and immunomodulatory effect of purified exopolysaccharides (EPSs) produced from vancomycin I resistant Enterococcus faecalis[J]. Int J Drug Deliv Tech, 2020, 10(4):523-529.
[69] HUANG S L, YU Q H, XIE L Y, et al. Inhibitory effects of Lactobacillus plantarum metabolites on porcine epidemic diarrhea virus replication[J]. Res Vet Sci, 2021, 139:32-42.
[70] LIU Z J, XU C, TIAN R, et al. Screening beneficial bacteriostatic lactic acid bacteria in the intestine and studies of bacteriostatic substances[J]. J Zhejiang Univ Sci B, 2021, 22(7):533-547.
[71] TACHEDJIAN G, ALDUNATE M, BRADSHAW C S, et al. The role of lactic acid production by probiotic Lactobacillus species in vaginal health[J]. Res Microbiol, 2017, 168(9-10):782-792.
[72] ÑAHUI PALOMINO R A, ZICARI S, VANPOUILLE C, et al. Vaginal Lactobacillus inhibits HIV-1 replication in human tissues ex vivo[J]. Front Microbiol, 2017, 8:906.
[73] GALDEANO C M, CAZORLA S I, DUMIT J M L, et al. Beneficial effects of probiotic consumption on the immune system[J]. Ann Nutr Metab, 2019, 74(2):115-124.
[74] TAGHINEZHAD-S S, MOHSENI A H, BERMÚDEZ-HUMARÁN L G, et al. Probiotic-based vaccines may provide effective protection against COVID-19 acute respiratory disease[J]. Vaccines (Basel), 2021, 9(5):466.
[75] ÑAHUI PALOMINO R A, VANPOUILLE C, LAGHI L, et al. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues[J]. Nat Commun, 2019, 10(1):5656.